Rujuk FatwaMalaysian fatwa reference
BM

FatwaSarawakPurification (Taharah)

HUKUM PENGGUNAAN PENANDAAN BERDAKWAT BAGI PESAKIT KANSER

Is it permissible to use ink markings in the treatment of cancer patients, and how does it affect ablution?

Short answer

The Sarawak State Fatwa Council ruled that ink markings used in cancer treatment are permissible.

SarawakFatwa committee decision

A reference, not a fatwa. First sentence of the summary below — read the original fatwa and consult your state authority before acting.

Authority
Sarawak State Mufti Department
Status
Fatwa committee decision
Series
Info Fatwa
Topic
Purification (Taharah)

No evidence of gazettement in the source — this is not a gazetted fatwa.

Summary

The Sarawak State Fatwa Council ruled that ink markings used in cancer treatment are permissible. This applies to Holbein Drawing Ink, whose contents have been verified as free of impurities (najis). Patients may perform ablution as usual because the ink is placed only beneath the surface of the skin.

Written in our own words from the original fatwa — check the source before acting on it.

Penggunaan tanda dakwat untuk rawatan pesakit kanser dengan menggunakan dakwat Holbein Drawing Ink yang telah disahkan kandungannya tidak mengandungi najis adalah diharuskan

Excerpt from the original fatwa · Sarawak

Read the full fatwa on the Sarawak website (new tab)

How to cite

Cite the original fatwa and its authority. Rujuk Fatwa is only where you found it.

Sarawak State Mufti Department. “HUKUM PENGGUNAAN PENANDAAN BERDAKWAT BAGI PESAKIT KANSER”, date not stated. https://muftinegeri.sarawak.gov.my/web/subpage/fatwa_list/#hukum-penggunaan-penandaan-berdakwat-bagi-pesakit-kanser. Found via Rujuk Fatwa: https://rujukfatwa.com/en/fatwa/is-ink-marking-allowed-cancer-patients-ablution/

Local graph

This fatwa and its nearest connections. The full lists are below.

See it on the full map

Related fatwas from other authorities

Chosen because the topic is close. Each is a separate fatwa — not necessarily an answer to the same question.